IVTPAIntravenous Recombinant Tissue Plasminogen Activator
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Data regarding door-to-needle and stroke onset-to-treatment time were measured for only those 16 patients who were treated with IVtPA.
Only 16 (30%) out of 54 individuals in our study were treated with IVtPA. Most of the patients receiving the IVtPA treatment visited the ED on weekdays (81%), at night (56%), or during off hours (63%).
Table 2 shows (by arrival category) the timeliness of IVtPA treatment for ischemic stroke patients in our study.
For the 54 ischemic stroke patients, both those receiving IVtPA and those not receiving IVtPA, the overall median of the door-to-CT-scan was 15 minutes (interquartile range [IQR] = 15).
Our results show that most of the patients treated with IVtPA arrived during off hours, even if their arrival was on a weekday, a finding which is similar to what has already been reported in the literature (17).
Ever since the European Cooperative Acute Stroke Study (ECASS III) published its findings, an increase in the use of IVtPA has been noted and median door-to-needle has decreased (20).